With 0.57 million shares changed hands, the volume of the stock remained heavier than its average volume of 41040.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.4575 whereas the lowest price it dropped to was $3.97. The 52-week range on SPRC shows that it touched its highest point at $37.59 and its lowest point at $4.00 during that stretch. Beta for the stock currently stands at 0.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SPRC was down-trending over the past week, with a drop of -6.21%, but this was down by -42.21% over a month. Three-month performance dropped to -34.13% while six-month performance fell -45.63%. The stock lost -44.05% in the past year, while it has lost -46.77% so far this year.
Float and Shares Shorts:
At present, 0.53 million SPRC shares are outstanding with a float of 0.53 million shares on hand for trading. On 2025-08-15, short shares totaled 11367.0, which was 213.00000999999997 higher than short shares on 1752537600. In addition to Mr. Itschak Shrem as the firm’s President & Director, Dr. Adi Zuloff-Shani Ph.D. serves as its Chief Technologies Officer.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.03038 being high and $0.03038 being low. For SPRC, this leads to a yearly average estimate of $0.03038.
